The table below shows Arcus Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$138.00M
-$132.00M
-$2.00M
-$98.00M
$654.00M
-$66.32M
Capital expenditure
$0.00
$1.00M
$4.00M
$3.00M
$3.00M
$3.64M
Investing cash flow
$114.00M
$32.00M
-$169.00M
$129.00M
-$268.00M
$62.83M
Dividends paid
-
-
-
-
RCUS operating cash flow (10-K history)
Arcus Biosciences, Inc. reported operating cash flow of -$482.00M for fiscal year 2025. That is down 183.5% from -$170.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$12.94M (FY 2016) to -$482.00M. Figures come from the company's audited annual reports as filed with the SEC.
